The Anti-Dengue Virus Peptide DV2 inhibits Zika Virus both in vitro and in vivo (2023)
- Authors:
- USP affiliated authors: FERNANDES, ANDREA BALAN - ICB ; FERREIRA, LUIS CARLOS DE SOUZA - ICB ; AMARANTE, MARIA FERNANDA DE CASTRO - ICB ; PEREIRA, SAMUEL SANTOS - ICB ; SANTOS, LUCAS SOUZA DOS - ICB ; CARVALHO, ALEXIA ADRIANNE VENCESLAU BRITO - ICB ; PEREIRA, LENNON RAMOS - ICB
- Unidade: ICB
- DOI: 10.3390/v15040839
- Subjects: MICROBIOLOGIA; PEPTÍDEOS; ZIKA VÍRUS; DENGUE ANIMAL; ANTIVIRAIS; FLAVIVIRUS; VÍRUS DA DENGUE; MODELOS ANIMAIS DE DOENÇAS; CAMUNDONGOS; INFECÇÕES POR VÍRUS DE RNA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
AMARANTE, Maria Fernanda de Castro et al. The Anti-Dengue Virus Peptide DV2 inhibits Zika Virus both in vitro and in vivo. Viruses, v. 15, n. 4, p. 1-11, 2023Tradução . . Disponível em: https://doi.org/10.3390/v15040839. Acesso em: 13 fev. 2026. -
APA
Amarante, M. F. de C., Pereira, S. S., Pereira, L. R., Santos, L. S., Carvalho, A. A. V., Martins, E. G., et al. (2023). The Anti-Dengue Virus Peptide DV2 inhibits Zika Virus both in vitro and in vivo. Viruses, 15( 4), 1-11. doi:10.3390/v15040839 -
NLM
Amarante MF de C, Pereira SS, Pereira LR, Santos LS, Carvalho AAV, Martins EG, Balan A, Ferreira LC de S. The Anti-Dengue Virus Peptide DV2 inhibits Zika Virus both in vitro and in vivo [Internet]. Viruses. 2023 ; 15( 4): 1-11.[citado 2026 fev. 13 ] Available from: https://doi.org/10.3390/v15040839 -
Vancouver
Amarante MF de C, Pereira SS, Pereira LR, Santos LS, Carvalho AAV, Martins EG, Balan A, Ferreira LC de S. The Anti-Dengue Virus Peptide DV2 inhibits Zika Virus both in vitro and in vivo [Internet]. Viruses. 2023 ; 15( 4): 1-11.[citado 2026 fev. 13 ] Available from: https://doi.org/10.3390/v15040839 - The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Omicron) SARS-CoV-2 variant
- Transcutaneous administration of dengue vaccines
- Nanovaccine based on self-assembling nonstructural protein 1 boosts antibody responses to Zika virus
- Association of high pressure and alkaline condition for solubilization of inclusion bodies and refolding of the NS1 protein from zika virus
- TLR2 axis on peripheral blood mononuclear cells regulates inflammatory responses to non-infectious immature dengue virus particles
- Enhanced immune responses and protective immunity to Zika vrus induced by a DNA vaccine encoding a chimeric NS1 fused wth tpe 1 Herpes vrus gD protein
- Layer-by-Layer assembly of polymeric nanoparticles with heparin-RBD complexes as an adjuvant for SARS-Cov-2 protein-based vaccines
- Protective immunity to Dengue virus induced by DNA vaccines encoding nonstructural proteins in a lethal challenge immunocompetent mouse model
- Diagnostic and vaccine potential of Zika virus envelope protein (E) derivates produced in bacterial and insect cells
- Specificity of NS1-based immunochromatographic tests for dengue virus with regard to the Zika virus protein
Informações sobre o DOI: 10.3390/v15040839 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
